ARK Genomic Revolution ETF (ARKG) es una empresa que cotiza en bolsa en el Servicios Financieros sector, operando dentro de la Asset Management industria.
ARKG tiene fecha de IPO 2014-10-31, cotiza en el Chicago Board Option, una capitalización de mercado de $1.18B.
ARKG is an actively managed Exchange Traded Fund (ETF) that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors that are relevant to the Fund’s investment theme of the genomics revolution.
